Development of defence medical countermeasures
The "Development of Defence Medical Countermeasures" program, part of the European Defence Fund (EDF), aims to enhance the EU's strategic autonomy in addressing Chemical, Biological, Radiological, and Nuclear (CBRN) threats. It provides funding for the innovation and development of medical countermeasures crucial for both armed forces and civilian protection. This initiative fosters shared capabilities and strengthens the EU's industrial capacity in defence medical technologies.
Who is Funded
This section details the eligibility criteria for applicants, the geographical scope of projects, and the core objectives of the "Development of Defence Medical Countermeasures" program. It outlines who can apply, where the projects should have an impact, and what the program aims to achieve in strengthening EU defence capabilities against CBRN threats.
What is Funded
This section describes the types of projects and activities supported by the "Development of Defence Medical Countermeasures" program, outlining the thematic areas, eligible activities, and targeted development stages. It clarifies the scope of innovations and developments expected to enhance CBRN defence.
Type and Scope of Funding
This section outlines the financial aspects of the "Development of Defence Medical Countermeasures" program, including the type of financial support, the overall budget allocated, and the expected project duration. It provides clarity on the nature and scale of funding available.
Conditions and Requirements
This section details the essential conditions and requirements for participation in the "Development of Defence Medical Countermeasures" program, covering admissibility criteria, application guidelines, and consortium rules. Adherence to these provisions is crucial for successful application and project implementation.
Application Procedure
This section outlines the procedural steps for applying to the "Development of Defence Medical Countermeasures" program, from preparing the necessary documentation to understanding the evaluation and award processes.
Legal Basis
This section identifies the foundational legal frameworks and official documents that underpin the "Development of Defence Medical Countermeasures" program, establishing its authority and operational guidelines.
Similar Programs
Funding Overview
Funding Status:
Closed
Allocated Budget:
50,000,000 € (for 2021)
Deadline:
08.12.2021
Open Until:
31.12.2027
Award Channel:
Framework Programme Call
Region:
European Union
Sectors:
Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Other
Beneficiaries:
EU armed forces, civilian sector
Application Type:
Consortium Required
Funding Stages:
Basic Research, Applied Research, Experimental Development, Feasibility Study, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Scaling, Commercialization
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Commission
Website: